HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Protective Effects of Protease Inhibitor MG-132 on Sepsis-Induced Acute Lung Rats and Its Possible Mechanisms.

Abstract
BACKGROUND The aim of the present study was to investigate the protective effects of protease inhibitor MG-132 on sepsis-induced acute lung injury rats. MATERIAL AND METHODS Sprague Dawley rats were employed to induce sepsis by cecal ligation and puncture (CLP) method. Rats were divided into 4 groups: control, sham, model (CLP), and MG-132. Histopathology observation was detected by hematoxylin and eosin staining. The ratio of wet lung to dry lung (W/D) was calculated. In addition, the levels of inflammatory factors in bronchoalveolar lavage fluid (BALF) were measured by enzyme-linked immunosorbent assay (ELISA). Also, superoxide dismutase (SOD) and malondialdehyde (MDA) levels were evaluated. Western blotting was performed to measure the expression of hypoxia-inducible factor-1 alpha (HIF-1alpha). In order to assess the role of HIF-1alpha, YC-1, the inhibitor of HIF-1alpha, was used to treat the rats. The expression of phosphor-mTOR (p-mTOR), p-4EBP1, and p-EIF4E were evaluated by western blotting. RESULTS Obvious pathological injury and increasing ratio of W/D in the model group were observed. Both pathological injury and W/D were improved in the MG-132 group, and the greatest improvement could be seen in the YC-1+MG-132 group. Furthermore, the MDA levels in the MG-132 group was decreased, accompanied by an increase in SOD levels. The level of HIF-1alpha was increased in the model group while a decreased was detected in the MG-132 group. The levels of inflammatory factors were high in the model group, whereas the opposite result was found in the MG-132 group, and the lowest in were in the YC-1+MG-132 group. Furthermore, the expression levels of p-mTOR, p-4EBP1, and p-EIF4E proteins were downregulated in the MG-132 group compared to the model group, and the lowest was in the YC-1+MG-132 group. CONCLUSIONS Our study suggested that MG-132 was able to protect against acute lung injury via inhibition of HIF-1alpha mediated mTOR/4EBP1/EIF4E pathway.
AuthorsBingbing Wu, Xiaoli Miao, Jilu Ye, Xuehua Pu
JournalMedical science monitor : international medical journal of experimental and clinical research (Med Sci Monit) Vol. 25 Pg. 5690-5699 (Aug 01 2019) ISSN: 1643-3750 [Electronic] United States
PMID31366881 (Publication Type: Journal Article)
Chemical References
  • Eif4ebp1 protein, rat
  • Eukaryotic Initiation Factor-4E
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Intracellular Signaling Peptides and Proteins
  • Leupeptins
  • Malondialdehyde
  • Superoxide Dismutase
  • TOR Serine-Threonine Kinases
  • benzyloxycarbonylleucyl-leucyl-leucine aldehyde
Topics
  • Acute Lung Injury (chemically induced, drug therapy, prevention & control)
  • Animals
  • Bronchoalveolar Lavage Fluid
  • China
  • Eukaryotic Initiation Factor-4E (metabolism)
  • Hypoxia-Inducible Factor 1, alpha Subunit (metabolism)
  • Intracellular Signaling Peptides and Proteins (metabolism)
  • Leupeptins (pharmacology)
  • Lung (pathology)
  • Malondialdehyde (metabolism)
  • Pulmonary Edema (metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Sepsis (complications)
  • Superoxide Dismutase (metabolism)
  • TOR Serine-Threonine Kinases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: